Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $78.33 on DaVita healthCare Partners Inc. (NYSE:DVA) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $3.95 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of DaVita healthCare Partners Inc. (NYSE:DVA) stands at 34.69. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For DaVita HealthCare Partners Inc., the PEG ratio for coming 3-5 years is 1.49. Technical Analysis The technical analysis highlights that DaVita HealthCare Partners Inc. current price is trading $0.81 points away +1.06% from $76.51, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $71.49 and, for now, the stock price is trading $5.83 or +8.16% away from that point. The 52-week high of DaVita healthCare Partners Inc. (NYSE:DVA) was $81.89 while lowest point recorded in 52-week was $61.36. It implies if stock price makes a movement of over $-4.57, it will record a new 52-week high. In the case of $+26.01% points drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know